Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 44847 in Female and Male Patients With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety, tolerability, pharmacokinetics and pharmacodynamics of multiple rising oral doses of BI 44847 in male and female patients with T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BI 44847

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED